Fatty Change Synonyms/subtypes Lipidosis, vacuolation, lipid, macrovesicular and/or microvesicular steatosis, phospholipidosis
With the generic GLP-1 race set to begin, this could: Disrupt global pricing Expand patient access Create major upside for pharma stocks According to ICICI Securities, key Indian players are gearing up to capitalize on this multi-billion-dollar opportunity
Study Selection The trials we included met the following criteria: (1) RCTs that compared GLP-1 receptor agonist with a placebo or active control (other antidiabetic drugs or insulin), (2) patients with type 2 diabetes, type 1 diabetes, prediabetes, overweight or obesity, (3) with durations of at least 24 weeks, and (4) reported the occurrence of at least one case of various thyroid disorders as adverse events
Strategies for appropriate selection of SGLT2-i vs
Population-Based, Multigenerational Family Clustering Study of Obsessive-compulsive Disorder
h tr ti to li ln da, chng lo ha cho da.